T61P (p.Thr61Pro) variant of IRS2 (Insulin receptor substrate 2)
T61P (p.Thr61Pro) in IRS2 (Insulin receptor substrate 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
T61P (p.Thr61Pro) variant details
- p.Thr61Pro
- NCI-TCGA TCGA novel
- Ensembl rs2138939468
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available